Karuna Therapeutics, Inc., A Bristol Myers Squibb Company

This study tested the long-term safety and effectiveness of an experimental drug called KarXT for people with schizophrenia. Over 500 adults took the medication twice daily for up to 52 weeks. Researchers tracked side effects and how well the drug controlled symptoms over time.

This study tested whether adding KarXT (a combination of two drugs) to regular antipsychotic treatment helps people with schizophrenia whose symptoms are not well controlled. 396 adults took either KarXT or a placebo for 6 weeks. The main goal was to see if KarXT reduced overall …

This study tested a new drug called KarXT in 202 Chinese adults hospitalized with schizophrenia. The goal was to see if KarXT could reduce symptoms like hallucinations and social withdrawal better than a placebo over 5 weeks. After that, everyone could receive KarXT for 12 more w…

This completed study looked at how a new drug called KarXT interacts with three common mood-stabilizing medications (lithium, valproic acid, and lamotrigine) in 133 healthy adults. The goal was to measure how these drugs affect each other's levels in the blood and to check for an…